Microsomal epoxide hydrolase is a xenobiotic metabolizing enzyme that catalyzes the conversion of toxic and carcinogenic epoxides to less toxic dihydrodiols. The cellular localization and distribution of microsomal epoxide hydrolase were investigated for the first time in normal and neoplastic human kidney. Light microscopic immunohistochemical studies using an alkaline phosphatase-anti-alkaline phosphatase technique showed that in normal kidney there was a wide distribution of epoxide hydrolase immunoreactivity. The main localization of epoxide hydrolase immunoreactivity was to the proximal and distal tubule epithelial cells. Strong epoxide hydrolase immunoreactivity was also identified in epithelium of the collecting ducts. In addition, epoxide
Introduction
The kidney is one of the major organs involved in the metabolism of xenobiotics, including drugs and toxic foreign compounds, together with various potential carcinogens and mutagens. Many of these compounds and also some endogenous compounds are metabolized to reactive electrophilic epoxide derivatives, usually by cytochrome P45O-mediated reactions (1,2). The epoxide hydrolases (3) are the group of detoxification enzymes that catalyze the conversion of epoxides to less toxic trans-dihydrodiols. The transdihydrodiols can then be conjugated with glutathione (4,5) or glucuronic acid and more readily excreted, although the tram-dihydrodiols may themselves be oxidized to produce diol epoxides, which are more reactive than the parent compounds. The major form of epoxide hydrolase is microsomal epoxide hydrolase (6,7) , which is membrane-bound and is present in the smooth endoplasmic reticulum. Other forms of epoxide hydrolase that have been identified are microsomal cholesterol epoxide hydrolase (8, 9) , cytosolic or ' Supported by grants from the Scottish Office Home and Health Department. RJW was a postdoctoral fellow supported by the Wellcome Foundation.
Correspondence to: Dr. Graeme I. Murray, Dept. of Pathology, U. of Aberdeen, Foresterhill, Aberdeen, UK AB9 2ZD. hydrolase immunoreactivity was present in vascular endothelial cells, including endothelial cells lining glomerular capillaries. Epoxide hydrolase immunoreactivity was identified in all the renal tumors, and in each tumor immunoreactivity for epoxide hydrolase was localized to tumor cells. Immunoblotting of both normal kidney and tumor microsomes confirmed the presence of a single protein band of molecular weight 49 KD soluble epoxide hydrolase (10-12), and cytosolic leukotriene A4 hydrolase (13,14), which differ in their substrate specificity and the effects of particular inhibitors (15-21).
Epoxides are toxic, and because they can bind to DNA and cell proteins and modify cell function epoxides are potentially carcinogenic andlor mutagenic. In view of the effect of epoxides on cell function, the expression of epoxide hydrolase appears to play a role in the development of tumors (22) .
In this study we investigated the cellular localization and distribution of microsomal epoxide hydrolase in normal and neoplastic human kidney.
Materials and Methods
Human Microsomal Epoxide Hydrolase Purification and Polydonal Antibody production. Human microsomal epoxide hydrolase was purified from human liver, essentially using the method of Weaver et al. (23) . The purified microsomal epoxide hydrolase gave a single band of molecular weight 49 KD on SDS-PAGE and showed high activity towards phenanthrene 9.10epoxide, which was determined by the method of Dansette et al. (24) . A polyclonal antibody was raised in rabbit against the purified human epoxide hydrolase as previously described (25) and purified by fractionation with 50% ammonium sulfate. Immunoblotting confirmed that the antibody recognized human hepatic microsomal epoxide hydrolase, and the antibody did not crossreact with cytosolic epoxide hydrolase, as there was no MCKAY, WEAVER, MURRAY, EWEN, MEIS", BURKE reaction when the antibody was immunoblotted against liver or kidney cytosol.
A discontinuous polyacrylamide gel system, as described by Laemmli (28) with modifications (23). was employed for separation of proteins in Tissue. Nephrectomy specimens excised for primary renal cell carcinoma and submitted to the Department of Pathology, University of Aberdeen, were used for this study. Six paired samples of normal kidney and tumor were used. Samples of normal kidney were taken at least several centimeters distant from the edge of each tumor, and only macroscopically viable tumor was sampled. The age range of the patients was 41-84 years; there were three men and three women. Samples of normal kidney and tumor tissue from each nephrectomy specimen were either rapidly frozen in liquid nitrogen and stored at -8O'C or fixed in 10% neutral buffered formalin for 24 hr and then processed to wax. The fresh frozen samples were used for both immunohistochemical and immunoblotting studies, and the fixed, embedded samples were used for immunohistochemical studies. Normal human livers were obtained from renal transplant donors, placed in ice-cold isotonic saline within 30 min of circulatory arrest, and stored at -80-C.
Immunohistochemistry. Frozen sections (6 wm) of kidney tissue were air-dried onto glass slides and then fixed in acetone for 15 min. Formalinfixed, wax-embedded sections of kidney tissue (4 Fm) were dewaxed in xylene and rehydrated in alcohol and spirit (95% alcohol), with each step being carried out for 5 min at room temperature (RT). After rinsing in cold water, all the sections were washed in 0.05 M Tris-HCI, pH 7.6, containing 0.15 M NaCl (TBS) before applying anti-epoxide hydrolase antibody at a dilution of 1:50 of a stock 20 mglml solution. prepared from the lyophilate of a 50% ammonium sulfate precipitate of immunized rabbit serum. An antigen retrieval step was not necessary before application of the primary antibody. Sections were incubated for 1 hr at RT and sites of bound antibody demonstrated using an alkaline phosphatase-anti-alkaline phosphatase (APAAP) technique (26) . The sections were sequentially incubated with monoclonal mouse anti-rabbit immunoglobulin (1:loO dilution; Dako, High Wycombe, Bucks, UK). rabbit anti-mouse immunoglobulin (1:lOO dilution containing 1% normal human serum; Dako), and monoclonal APAAP (1:lOO dilution; Dako) each for 30 min at RT. the sections being washed for two successive 5-min periods after each incubation to remove unbound antibody. Sites of bound alkaline phosphatase were demonstrated colorimetrically using a solution containing 3 mg bromochloro-indolyl phosphate (Sigma; Poole, Dorset, UK), 10 mg nitroblue tetrazolium (Sigma), 6 mg sodium azide, and 4 mg levamisole (Sigma) in 10 ml0.05 M 3is-HCI buffer, pH 9.0, containing 0.2% magnesium chloride. The sections were incubated for 30 min at RT, and the reaction stopped by washing in cold water. The slides were then air-dried and mounted in glycerin jelly before being examined by light microscopy to determine qualitatively the presence or absence of immunostaining, and its distribution. Normal rabbit serum and TBS were used as negative controls in place of the primary antibody, and a positive control was sections of formalin-fixed. wax-embedded normal human liver, which is known to express microsomal epoxide hydrolase.
Immunoblotting. Microsomes were prepared as prcviously described (23) . Briefly, tissue samples were thawed in 25 mlO.01 M Tris-HC1 buffer, pH 7.4, containing 1.15% KCI before being homogenized in 0.01 M Tris-HCI buffer, pH 7.4, containing 0.25 M sucrose, 15% glycerol, using an Ultra-Turrax homogenizer (type TP 18/2; J a d e and Kunkel AG, Staufen Breisgau, Germany). After centrifugation at 15,000 x g for 20 min, the supernatant was removed and recentrifuged at 116,000 x g for 50 min. The pellet from this spin was re-suspended in 0.1 M Tris-HC1 buffer, pH 7.4, containing 15% glycerol, 1 mM EDTA, recentrifuged at 116,000 x g for 50 min. and the pellet finally re-suspended in Tr~-HCl-glycerol-E~ buffer. Microsomal protein concentration was determined by the method of Lowry (27) . The microsomes prepared from six normal kidney samples and their corresponding primary tumors had protein concentrations ranging from 2.4 mglml to 8.4 mglml. the kidney microsomes. Twenty ~1 of a 1 mglml preparation of normal samples and 40 p1 of a 0.5 mglml preparation of tumor samples in 0.125 M Tris-HCI, pH 6.8, containing 2.35% (wlv) sodium dodecyl sulfate (SDS; Sigma), 5% (vlv) 2-mercaptoethanol, and 0.005 % bromophenol blue tracking dye were loaded onto the gel, with 10 p1 of a 1 mg/ml preparation of human liver microsomes and 1 pg and 2 wg loadings of purified human hepatic microsomal epoxide hydrolase used as positive controls. Samples were run on a 10% non-gradient gel at 30 mA, and resolved proteins blotted onto a nitrocellulose membrane (Schleicher & Schuell; Dassel, Germany) overnight as described by Towbin et al. (29) . Nonspecific binding sites were blocked with PBS containing 2% (wlv) M m l , 0.05 % (v/v) Tween 20 for 30 min at RT with continuous shaking, this buffer also being also being used for washing stages. The nitrocellulose membrane was then incubated with anti-epoxide hydrolase (1:lOOO) for 90 min and goat anti-rabbit immunoglobulin horseradish peroxidase conjugate (1:2OOo; Bio-Rad Laboratories. Hemel Hempsted, Herts, UK) for 60 min. The membrane was washed for three successive 15-min periods and one 60-min period after each incubation to remove unbound antibody. Bound horseradish peroxidase was then visualized with an Enhanced Chemiluminescence (ECL) kit (Amersham International; Aylesbury, Bucks, UK). Detection was carried out as described in the ECL protocol, with the X-ray film (Hyperfilm-ECL Amersham) being exposed for 30 sec.
Immtlnohistochemistry
Normal Kidney. Both frozen sections and formalin-fixed, waxembedded sections of kidney gave an identical distribution of epoxide hydrolase immunoreactivity. In normal kidney, strong immunoreactivity for epoxide hydrolase was identified within the cortex and the medulla. Immunoreactivity for epoxide hydrolase was present in the proximal and distal convoluted tubules (Figure 1 ). Marked epoxide hydrolase immunoreactivity was also present in the tubule epithelial cells located in the medulla (Figure 2 ), and the epithelial cells of the collecting ducts also displayed immunoreactivity for epoxide hydrolase. Immunostaining was identified as strong homogeneous cytoplasmic staining of cells without nuclear staining, and there was no apparent staining of the microvillous border of tubule cells. Immunoreactivity for epoxide hydrolase was also demonstrated in endothelial cells of renal vessels, including glomerular capillaries, and there was weak immunostaining of some of the epithelial cells of the parietal layer of Bowman's capsule. No immunoreactivity for epoxide hydrolase was observed in connective tissue, and immunostaining was abolished when the epoxide hydrolase antibody was replaced by normal rabbit serum or TBS in the immunohistochemical procedure (Figure 3) .
Kidney Tumors. All the tumors studied were primary renal cell carcinomas, and each tumor showed a variable histological pattern with solid areas and papillary areas. Cytologically, the tumors contained a variable number of clear cells and tall columnar cells. Positive immunoreactivity for epoxide hydrolase was identified in all the renal tumors. There was positive staining within tumor cells, and the precise pattern of immunoreactivity depended on the cytology of the tumor cells. Strong diffuse cytoplasmic immunoreactivity was identified in columnar tumor cells (Figure 4) , but hmunoreactivity for epoxide hydrolase was less intense in clear cells, with only a rim of cytoplasmic staining present at the periphery McKAY, WEAVER, MURRAY, EWEN, MELVIN, BURKE of the cells. There was no immunostaining for epoxide hydrolase within the connective tissue surrounding groups of tumor cells.
Immunoblotting
Immunoblotting of both normal and tumor kidney microsomes showed a single band of molecular weight 49 KD corresponding to the band observed in human liver microsomes and purified human hepatic microsomal epoxide hydrolase (Figures 5-7) . Microsomes prepared from the different normal kidney samples each gave a stronger band than microsomes prepared from the renal tumors, although the amount of protein loaded in every sample was identical. Normal human liver microsomes and purified epoxide hydrolase each gave a stronger band than either the normal or the tumor microsomes.
Discussion
The kidney is a major site of xenobiotic metabolism in the body and is an important target organ for damage by toxic foreign compounds. Therefore, it is important to identify the various xenobiotic metabolizing enzymes present in the kidney and their precise cellular localization. The ability of such enzymes to either activate or detoxify potential renal toxins, including carcinogens, that enter the kidney may have a profound effect on the likelihood of toxicity occurring in this tissue, and the sites of toxicity will depend on the cell-specific expression of particular xenobiotic metabolizing enzymes and their relative content. Furthermore, the presence of xenobiotic metabolizing enzymes in established tumors may exert an effect on the efficiency of anti-cancer drugs (30) and may contribute to the response of tumors to these therapeutic agents. Microsomal epoxide hydrolase is the key enzyme involved in the metabolism of epoxides (3,7) , and in this study we investigated the localization and cellular distribution of microsomal epoxide hydrolase in both normal and human kidney and primary renal cell carcinomas.
The localization and cellular distribution of epoxide hydrolase have not been investigated in human kidney, although the presence of epoxide hydrolase in normal human kidney has been shown by immunoblotting (31) and epoxide hydrolase activity has also been identified in kidney microsomes (32). In normal kidney, the main localization of epoxide hydrolase was to both proximal and distal tubule epithelial cells, indicating that tubule cells are the main site of epoxide metabolism. The localization of microsomal epoxide hydrolase to tubule epithelial cells is similar to that observed for glutathione S-transferases (5). a family of xenobiotic metabolizing enzymes that can further metabolize the products of epoxide hydrolase metabolism.
Although the main identified role of epoxide hydrolase appears to be the metabolism of epoxides produced by the metabolism of xenobiotics. recently a physiological function for epoxide hydrolase has been identified within liver, i.e., as a mediator protein involved in bile acid transport (33). In view of the widespread distribution of epoxide hydrolase in normal kidney, and in particular its localization in tubule epithelial cells, it is possible that microsomal epoxide hydrolase also has a physiological function in the kidney and may be involved in transporting substances within tubule epi- thelia1 cells. In addition, it may be a regulatory enzyme for tubule water and ion transport, as it can metabolize epoxyeicosatrienoicacids, which have an important role in modulating water and salt metabolism in tubule epithelial cells (34,35) . Similarly, the presence of epoxide hydrolase in vascular endothelium suggests that epoxide hydrolase has a physiological role in endothelium, most likely via the metabolism of epoxyeicosatrienoicacid derivatives that are vasoactive (35).
Primary renal cancer is a relatively rare tumor, its development may be associated with environmental toxins (36), and established tumors respond poorly to anti-cancer drugs. The presence of epoxide hydrolase in normal kidney indicates that epoxide hydrolase may have a role in the development of renal tumors, and in a rodent model of chemically induced primary renal tumors the microsomal epoxide hydrolase level has been shown to be elevated during tumor formation (37).
In all the renal tumors, immunoreactivity was confined to tumor cells, suggesting that tumors may be able to detoxify meta-bolically produced epoxides. Epoxide hydrolase has not previously been identified in kidney tumors. However, the expression of epoxide hydrolase has been consistently demonstrated in other types of tumor, including liver (38), colon (25,39) and lung (40) , s u g gesting that epoxide hydrolase expression is a molecular event in malignancy and that the presence of epoxide hydrolase in tumors may contribute to the response of tumors to anti-cancer drugs (30) 
